Young women's constructions of the HPV vaccine: A cross-cultural, qualitative study in Scotland, Spain, Serbia and Bulgaria

International Journal of Behavioral Medicine

Volumn 21, Issue 1, 2014, Pages 11-19

  Gray Brunton, Carol ^a   Farver, Ingeborg ^b   Jäger, Moritz ^c   Lenneis, Anita ^d   Parve, Kadi ^e   Patarcic, Dina ^f   Petrova, Dafina ^g   Hogg, Rhona ^a,h   Kennedy, Catriona ^a,i   Garcia Retamero, Rocio ^g   Todorova, Irina ^j  

^a EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

^b AARHUS UNIVERSITY   (Denmark)

^c University of Vienna ^*

^d UNIVERSITY OF VIENNA   (Austria)

^e TALLINN UNIVERSITY   (Estonia)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITY OF GRANADA   (Spain)

^h NHS LOTHIAN   (United Kingdom)

ⁱ UNIVERSITY OF LIMERICK   (Ireland)

^j NORTHEASTERN UNIVERSITY   (United States)

more..

Author keywords

Cervical cancer; European; HPV vaccine; Qualitative; Young women

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; BULGARIA; CULTURAL FACTOR; FEMALE; HUMAN; INFORMATION PROCESSING; PAPILLOMAVIRUS INFECTION; QUALITATIVE RESEARCH; SERBIA; SPAIN; UNITED KINGDOM; UTERINE CERVIX TUMOR; VIROLOGY; WOMEN'S HEALTH; YOUNG ADULT;

ADOLESCENT; ADULT; BULGARIA; CROSS-CULTURAL COMPARISON; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUALITATIVE RESEARCH; SCOTLAND; SERBIA; SPAIN; UTERINE CERVICAL NEOPLASMS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 84898947503     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12529-013-9357-3     Document Type: Article

References (40)

1. (ECCA) ECCA. HPV vaccination across Europe 2009.
2. La Torre G, de Waure C, Chiaradia G, Mannocci A, Ricciardi W. HPV vaccine efficacy in preventing persistent cervical HPV infection: a systematic review and meta-analysis. Vaccine. 2007;25(50): 8352-8. doi:10.1016/j.vaccine.2007.09. 027. (Pubitemid 350137594)
3. Lowy DR, Schiller JT. Reducing HPV-associated cancer globally. Cancer Prev Res (Phila). 2012;5(1):18-23. doi:10.1158/1940-6207.capr-11-0542.
4. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008;43(4 Suppl):S5-S25. doi:10.1016/j.jadohealth.2008.07.009. Se1-41.
5. Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007;85(9):719-26. (Pubitemid 47416724)
6. Arbyn M, Primic-Zakelj M, Raifu AO, Grce M, Paraskevaidis E, Diakomanolis E, et al. The burden of cervical cancer in south-east Europe at the beginning of the 21st century. Coll Antropol. 2007;31 Suppl 2:7-10.
7. Arbyn M, Raifu AO, Autier P, Ferlay J. Burden of cervical cancer in Europe: estimates for 2004. Ann Oncol. 2007;18(10):1708-15. doi: 10.1093/annonc/mdm079. (Pubitemid 47506260)
8. Peto J, Gilham C, Fletcher O, Mathews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364(9430):249-56. doi:10.1016/S0140-6736(04)16674-9. (Pubitemid 38942814)
9. International Agency for Research on Cancer, World Health Organisation. Use of screening for cervical cancer. In: Handbooks of cancer prevention, volume 10: cervix cancer screening. Lyon: IARC Press; 2005. p. 117-62. http://www.iarc.fr/en/publications/pdfs-online/prev/handbook10/index.php.
10. Avramova L, Alexandrova D, Balabanova J, Bradley J, Panayotova Y, Todorova I. Cervical cancer screening in Bulgaria: psychosocial aspects and health systems dimensions. Sofia: Health Psychology Research Center & Engender Health; 2005.
11. Perišić Ž, Plešinac-Karapandžić V, Džinić M, Zamurović M, Perišić N. Cervical cancer screening in Serbia. Vojnosanit Pregl. 2013;70(1):86-9.
12. Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, et al. Human papillomavirus vaccine introduction - the first five years. Vaccine. 2012;30 Suppl 5:F139-48. doi:10.1016/j.vaccine.2012.05.039.
13. Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, et al. An overview on the implementation of HPV vaccination in Europe. Hum Vaccin. 2011;7(Suppl):128-35.
14. Division NIS. HPV immunisation uptake statistics: HPV immunisation programme - school year 2011/12. 2012.
15. Katz ML, Reiter PL, Heaner S, Ruffin MT, Post DM, Paskett ED. Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine. 2009;27(30):3945-52. doi:10.1016/j. vaccine.2009.04.040.
16. Lechuga J, Swain GR, Weinhardt LS. The cross-cultural variation of predictors of human papillomavirus vaccination intentions. J Women's Health (Larchmt). 2011;20(2):225-30. doi:10.1089/jwh.2010.1993.
17. Rosenthal D, Dyson S, Pitts M, Garland S. Challenges to accepting a human papilloma virus (HPV) vaccine: a qualitative study of Australian women. Women Health. 2007;45(2):59-73. doi:10.1300/J013v45n02-04.
18. Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wilson S. Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination. BMC Public Health. 2008;8:368. doi:10.1186/1471-2458-8-368.
19. Mortensen GL. Drivers and barriers to acceptance of humanpapillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health. 2010;10:68. http://www.biomedcentral.com/1471-2458/10/68.
20. Roberts ME, Gerrard M, Reimer R, Gibbons FX. Mother-daughter communication and Human Papillomavirus vaccine uptake by college students. Pediatrics. 2010;125:982-9. doi:10.1542/peds.2009-2888.
21. Hobson-West P. Trusting blindly can be the biggest risk of all: organised resistance to childhood vaccination in the UK. Sociol Health Illn. 2007;29(2):198-215.
22. Todorova I, Baban A, Alexandrova-Karamanova A, Bradley J. Inequalities in cervical cancer screening in Eastern Europe: perspectives from Bulgaria and Romania. Int J Public Health. 2009;54(4): 222-32. doi:10.1007/s00038-009-8040-6.
23. Löwy I. HPV vaccination in context: a view from France. In:Wailoo K, Livingston J, Epstein S, Aronowitz R, editors. Three shots at prevention: the HPV vaccine and the politics of medicine's simple solutions. Baltimore: The John Hopkins University Press; 2010. p. 270-92.
24. Stöckl A. Public discourse and policymaking: the HPV vaccination from the European perspective. In: Wailoo K, Livingston J, Epstein S, Aronowitz R, editors. Three shots at prevention: the HPV vaccine and the politics of medicine's simple solutions. Baltimore: The John Hopkins University Press; 2010. p. 254-69.
25. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2-3):107-14. doi:10.1016/j.ypmed.2007.05.013. (Pubitemid 47348081)
26. Juraskova I, O'Brien M, Mullan B, Bari R, Laidsaar-Powell R, McCaffery K. HPV vaccination and the effect of information framing on intentions and behaviour: an application of the theory of planned behaviour and moral norm. Int J Behav Med. 2012;19(4):518-25. doi:10.1007/s12529-011-9182-5.
27. Lyons AC. Advancing and extending qualitative research in health psychology. Health Psychol Rev. 2011;5(1):1-8.
28. Waller J, Marlow LAV, Wardle J. Mothers' attitudes towards precenting cervical cancer through Human Papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev. 2006;15:1257-67. doi: 10.1158/1055-9965.
29. Robbins SCC, Bernard D, McCaffery K, Brotherton J, Garland S, Skinner SR. "Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination. Vaccine. 2010;28(19):3398-408. doi:10.1016/j.vaccine.2010.02.078.
30. Hilton S, Smith E. "I thought cancer was one of those random things. I didn't know cancer could be caught": adolescent girls' understandings and experiences of the HPV programmed in the UK. Vaccine. 2011;29(26):4409-15.
31. Boyce T, Holmes A. Addressing health inequalities in the delivery of the human papillomavirus vaccination programme: examining the role of the school nurse. PLoS ONE. 2012;7(9):e43416. doi:10.1371/journal.pone.0043416.
32. Todorova I, Alexandrova-Karamanova A, Panayotova Y, Dimitrova E, Kotzela T. Managing uncertainty: healthcare professionals' meanings regarding the HPV vaccine. Int J Behav Med. (In press).
33. Hopfer S, Clippard JR. College women's HPV vaccine decision narratives. Qual Health Res. 2011;21(2):262-77. doi:10.1177/1049732310383868.
34. Petrova D, Gray Brunton C, Jaeger M, Lenneis A, Muñoz R, Garcia-Retamero R, et al. The views of young women on the human papilloma virus vaccine communication in four European countries. (Submitted manuscript).
35. Bulgaria TOPotCoMoR. National program for primary prevention of cervical cancer in Bulgaria, 2012-2017.
36. Brislin RW. Back-translation for cross-cultural research. J Cross-Cult Psychol. 1970;1(3):185-216.
37. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2005;3:77-101.
38. Petrova D, Gray C, Farver I, Jaeger M, Lenneis A, et al. Young women's experiences of the HPV vaccine: a cross-cultural, qualitative study in Scotland, Spain, Serbia and Bulgaria. 26th European Health Psychology Society Conference, 21-25 August, Prague, Czech Republic.
39. Willig C. Foucauldian discourse analysis. In: Willig C, editor. Introducing qualitative research in psychology. 2nd ed. New York: McGraw-Hill; 2008. p. 112-31.
40. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103): 637-41. (Pubitemid 28098447)